DUBLIN, Ireland and BRIDGEWATER, N.J., May 21, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced support for a clinical trial to investigate the effects of icosapent ethyl ...

NEW YORK (CBSNewYork)-- Some important news was announced Thursday about a way for many Americans to reduce their risk for heart attack and stroke. It's a drug that some are calling "super fish oil," ...

, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today presented additional data on Vascepa® (icosapent ethyl) and its ...

The drug is called Vascepa (icosapent ethyl), and it's geared toward adults with high risk of heart attacks due to bad cholesterol and other contributors like smoking, high blood pressure, obesity, ...

Sept. 29, 2021 Updated Wed., Sept. 29, 2021 at 10:54 a.m. This undated photo provided by Amarin in November 2018 shows a capsule of the purified, prescription fish oil Vascepa. On Dec. 13, 2019, U.S.

The agency said this was the first such approval, as the purified omega-3 fatty acid is now approved to be used alongside statins to treat elevated cholesterol levels and cut the risk of events such ...

Government health experts on Thursday recommended broader use of a prescription-strength fish oil drug to help many more patients at risk for heart attack, stroke and related health problems.

U.S. regulators on Friday approved expanded use of a fish oil-based drug for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. Vascepa was ...